Ensayos clínicos de Migraña en Nebraska
8 estudios sobre Migraña buscan participantes en Nebraska.
Ciudades en Nebraska
Texto oficial del estudio (inglés)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital & Medical Center, Omaha
ReclutandoFase 1
Edades de 6 a 11 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Grand Island, Grand Island
- Papillion Research Center/CCT Research, Papillion
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital & Medical Center, Omaha
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital & Medical Center, Omaha
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Cct Research - Papillion Research Center /ID# 270393, Papillion
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Nebraska Medical Center, Omaha
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 16 sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Cognitive Clinical Trials (CCT) - Papillion /ID# 232552, Papillion
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Tri City Research Center, LLC /ID# 278800, Grand Island
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 feb 2026 · NCT07310290De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.